Abstract
ABSTRACTGinger has been associated with a decreased incidence of colorectal cancer (CRC) through reduction in inflammatory pathways and inhibition of tumor growth. Recent pre-clinical models have implicated changes in the gut microbiome as a possible mediator of the ginger effect on CRC. We hypothesized that, in adults previously diagnosed with a colorectal adenoma, ginger supplementation would alter the fecal microbiome in the direction consistent with its CRC-inhibitory effect. Sixty-eight adults were randomized to take either ginger or placebo daily for 6 weeks, with a 6-week washout and longitudinal stool collection throughout. We performed 16S rRNA sequencing and evaluated changes in overall microbial diversity and the relative abundances of pre-specified CRC-associated taxa using mixed-effects logistic regression. Ginger supplementation showed no significant effect on microbial community structure through alpha or beta diversity. Of 10 pre-specified CRC-associated taxa, there were significant decreases in the relative abundances of the generaAkkermansia(p<0.001),Bacteroides(p=0.018), andRuminococcus(p=0.013) after 6-week treatment with ginger compared to placebo. Ginger supplementation led to decreased abundances ofAkkermansiaandBacteroides, which suggests that ginger may have an inhibitory effect on CRC-associated taxa. Overall, ginger supplementation appears to have a limited effect on gut microbiome in patients with colorectal adenomas.
Publisher
Cold Spring Harbor Laboratory
Reference31 articles.
1. SEER Cancer Annual Report to the Nation 2021: Overall Cancer Statistics. 2021; Available from: https://seer.cancer.gov/report_to_nation/statistics.html.
2. Howlader, N. , et al., SEER Cancer Statistics Review, 1975-2016. National Cancer Institute: Bethesda, MD.
3. Human Gut Microbiome and Risk for Colorectal Cancer
4. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
5. The gut microbiota in conventional and serrated precursors of colorectal cancer